The O&P profession has long understood something that policymakers are only now beginning to recognize: outcomes matter.
For decades, O&P clinicians have focused on restoring mobility, preventing falls, improving independence, and improving quality of life. Yet despite these contributions, the profession has often struggled to demonstrate its value in a way that resonates with payers and policymakers. A new whitepaper from the Limb Loss and Preservation Registry (LLPR), The Medicare Advantage Final Rule: A Defining Moment for O&P—and Why Data Will Decide Who Wins, argues that this challenge can no longer be ignored.
The “Announcement of Calendar Year (CY) 2027 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies” from the Centers for Medicare & Medicaid Services (CMS) signals more than a routine regulatory update. It reflects a broader shift toward outcomes-based accountability across healthcare. While Medicare Advantage plans will receive additional funding, CMS is simultaneously increasing expectations around quality measurement, patient outcomes, and value-based performance. Providers who can demonstrate measurable results will be better positioned to succeed in this environment. Those who cannot may find themselves increasingly marginalized.
For the O&P profession, this represents a fundamental change in how value must be communicated.
Historically, O&P has relied on clinical expertise, narrative documentation, and individualized patient care to justify treatment decisions. While those elements remain essential, they are no longer sufficient in a healthcare system increasingly driven by data, benchmarking, and standardized performance metrics. CMS is moving from a model of professional discretion to one of verification, relying on measurable outcomes and longitudinal data to inform policy and reimbursement decisions.
The challenge is that O&P has not traditionally had access to the large-scale outcomes infrastructure found in many other healthcare sectors. Yet the profession directly influences many of the outcomes Medicare Advantage plans now prioritize, including mobility, functional independence, fall prevention, chronic disease management, mental health, and quality of life. These outcomes are becoming central to payer decision-making and long-term cost management.
One of the industry’s most significant gaps is the lack of patient-reported outcomes data collected at scale from individuals living with limb loss, limb difference, and limb-threatening conditions. While providers gather important clinical information within their practices, the profession has lacked a mechanism for capturing the lived experiences, functional outcomes, and quality-of-life measures reported directly by patients across the broader population.
To help address this challenge, the LLPR is launching the Limb Outcomes Voice (LOV), a new patient-centered platform designed to collect patient-reported outcome measures (PROMs) directly from individuals in the limb-loss and limb-preservation community. Through brief surveys administered throughout the year, LOV captures information related to mobility, physical function, pain, sleep, falls, satisfaction, and overall quality of life. The initiative is designed to generate real-world evidence that complements clinical outcomes data and provides a more complete picture of patient experiences.
The significance of this effort extends beyond research. As health plans adapt to the Medicare Advantage final rule, providers should expect greater demands for outcomes reporting, more selective provider networks, increased value-based contracting, and stronger justification for device selection and clinical pathways. The ability to demonstrate outcomes using credible patient-reported data may soon become a competitive necessity rather than a differentiator.
The LLPR whitepaper argues that the profession must move beyond viewing outcomes measurement as a research activity and begin treating it as business-critical infrastructure. Standardized outcome measures, longitudinal patient follow-up, provider benchmarking, and population-level reporting are rapidly becoming strategic necessities.
This is where the combination of LLPR and LOV becomes particularly important. Together, they create an expanding source of clinical and patient-reported outcomes data that can help providers demonstrate value, benchmark performance, support payer negotiations, and contribute to a stronger national narrative about the impact of O&P care.
The final rule should be viewed not as a threat, but as an opportunity. O&P has always been an outcomes-driven profession. The difference today is that outcomes must be measured, standardized, and reported at scale.
Organizations that actively participate in data collection initiatives such as the LLPR will be better positioned to thrive in a healthcare environment increasingly defined by evidence-based decision-making. As the volume of patient-reported and clinical outcomes data grows through LLPR and LOV, the profession has an opportunity not only to respond to changing expectations, but to help define them.
The future of O&P will belong to organizations that embrace data as a strategic asset. In this new environment, value is no longer assumed.
It must be proven.
Shawn Murphy is the executive director of the Limb Loss and Preservation Registry. She can be contacted at shawn.murphy@thoughtfoundation.org.
